135 related articles for article (PubMed ID: 30026005)
21. Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China.
Zou X; Chang K; Wang Y; Li M; Zhang W; Wang C; Lu B; Xiong Z; Han J; Zhang Y; Zhao J; Cao B;
Int J Infect Dis; 2019 Mar; 80():92-97. PubMed ID: 30634045
[TBL] [Abstract][Full Text] [Related]
22. Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay.
Isles N; Badman SG; Ballard S; Zhang B; Howden BP; Guy R; Williamson DA
Pathology; 2022 Feb; 54(1):120-122. PubMed ID: 34776245
[No Abstract] [Full Text] [Related]
23. Prospective and retrospective evaluation of the Cepheid Xpert® Flu/RSV XC assay for rapid detection of influenza A, influenza B, and respiratory syncytial virus.
Salez N; Nougairede A; Ninove L; Zandotti C; de Lamballerie X; Charrel RN
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):256-8. PubMed ID: 25662018
[TBL] [Abstract][Full Text] [Related]
24. Rapid differential diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial viruses: Validation of a novel RT-PCR assay.
Domnich A; Bruzzone B; Trombetta CS; De Pace V; Ricucci V; Varesano S; Garzillo G; Ogliastro M; Orsi A; Icardi G
J Clin Virol; 2023 Apr; 161():105402. PubMed ID: 36805601
[TBL] [Abstract][Full Text] [Related]
25. A novel PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of influenza virus infection.
Schmidt RLJ; Simon A; Popow-Kraupp T; Laggner A; Haslacher H; Fritzer-Szekeres M; Redlberger-Fritz M; Mayer FJ
Clin Microbiol Infect; 2019 Aug; 25(8):1032-1037. PubMed ID: 30583060
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the molecular Xpert Xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses.
Chen JH; Lam HY; Yip CC; Cheng VC; Chan JF; Leung TH; Sridhar S; Chan KH; Tang BS; Yuen KY
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):177-180. PubMed ID: 29262988
[TBL] [Abstract][Full Text] [Related]
27. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.
Mostafa HH; Carroll KC; Hicken R; Berry GJ; Manji R; Smith E; Rakeman JL; Fowler RC; Leelawong M; Butler-Wu SM; Quintero D; Umali-Wilcox M; Kwiatkowski RW; Persing DH; Weir F; Loeffelholz MJ
J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298613
[TBL] [Abstract][Full Text] [Related]
28. Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.
Kim SH; AlMutawa F
Microbiol Spectr; 2022 Jun; 10(3):e0039922. PubMed ID: 35583359
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Cepheid Xpert Flu/RSV XC and BioFire FilmArray for Detection of Influenza A, Influenza B, and Respiratory Syncytial Virus.
Wahrenbrock MG; Matushek S; Boonlayangoor S; Tesic V; Beavis KG; Charnot-Katsikas A
J Clin Microbiol; 2016 Jul; 54(7):1902-1903. PubMed ID: 27098956
[TBL] [Abstract][Full Text] [Related]
30. Initial performance evaluation of a spotted array Mobile Analysis Platform (MAP) for the detection of influenza A/B, RSV, and MERS coronavirus.
Hardick J; Metzgar D; Risen L; Myers C; Balansay M; Malcom T; Rothman R; Gaydos C
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):245-247. PubMed ID: 29550057
[TBL] [Abstract][Full Text] [Related]
31. Clinical Performance of the AllplexTM Respiratory Panel 1 Test Compared to SimplexaTM Flu A/B and RSV for Detection of Influenza Virus and Respiratory Syncytial Virus Infection Including Their Subtyping.
Kim J; Nam J; Jang W; Lim CS
Med Princ Pract; 2019; 28(4):380-386. PubMed ID: 30831570
[TBL] [Abstract][Full Text] [Related]
32. A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses.
Davies S; Boller E; Chase J; Beaubrun A; Miller C; Jensen I
J Med Econ; 2024; 27(1):430-441. PubMed ID: 38328858
[TBL] [Abstract][Full Text] [Related]
33. Comparative practicability and analytical performances of Credo VitaPCR™ Flu A&B and Cepheid Xpert® Xpress Flu/RSV platforms.
Mboumba Bouassa RS; Tonen-Wolyec S; Rodary J; Bélec L
Diagn Microbiol Infect Dis; 2021 Aug; 100(4):115381. PubMed ID: 33852989
[TBL] [Abstract][Full Text] [Related]
34. Influenza and RSV incidence during COVID-19 pandemic-an observational study from in-hospital point-of-care testing.
Stamm P; Sagoschen I; Weise K; Plachter B; Münzel T; Gori T; Vosseler M
Med Microbiol Immunol; 2021 Dec; 210(5-6):277-282. PubMed ID: 34604931
[TBL] [Abstract][Full Text] [Related]
35. Near point-of-care adoption of Cepheid Xpert® Flu/RSV XC testing within an integrated healthcare delivery network.
Hernandez DR; Pellitteri GP; Kimmich DJ; Heiter BJ; Smeal K; Wolk DM
Diagn Microbiol Infect Dis; 2019 May; 94(1):28-29. PubMed ID: 30581009
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the IMDx influenza A virus, influenza B virus, and respiratory syncytial virus A/B assay on the m2000 platform with real-time reverse transcriptase PCR assays.
Adachi D; Tang JW; Lundeberg R; Tipples G; Charlton CL; Drews SJ
J Clin Microbiol; 2014 Dec; 52(12):4441-2. PubMed ID: 25275003
[No Abstract] [Full Text] [Related]
37. Performance evaluation of direct fluorescent antibody, Focus Diagnostics Simplexa™ Flu A/B & RSV and multi-parameter customized respiratory Taqman® array card in immunocompromised patients.
Steensels D; Reynders M; Descheemaeker P; Curran MD; Jacobs F; Denis O; Delforge ML; Montesinos I
J Virol Methods; 2017 Jul; 245():61-65. PubMed ID: 28365410
[TBL] [Abstract][Full Text] [Related]
38. Rapid diagnosis of influenza: an evaluation of two commercially available RT-PCR assays.
Li M; Brenwald N; Bonigal S; Chana K; Osman H; Oppenheim B
J Infect; 2012 Jul; 65(1):60-3. PubMed ID: 22522291
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput.
Phan T; Tran NYK; Gottlieb T; Siarakas S; McKew G
Pathology; 2022 Jun; 54(4):466-471. PubMed ID: 35461715
[TBL] [Abstract][Full Text] [Related]
40. Antigen-based assays for the identification of influenza virus and respiratory syncytial virus: why and how to use them in pediatric practice.
Principi N; Esposito S
Clin Lab Med; 2009 Dec; 29(4):649-60. PubMed ID: 19892226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
